Clinical Trials Logo

Clinical Trial Summary

In children aged 3 months to 10 years who present to the Pediatric Emergency Department (PED) with recent, significant vomiting and moderate dehydration, is treatment with Ondansetron Orally Disintegrating Tablet (ODT) better tolerated than treatment with Ondansetron Oral Solution (OS)? Our hypothesis is that children who receive Ondansetron ODT will have 10% less vomiting within 15 minutes of administration than those receiving Ondansetron OS.


Clinical Trial Description

Vomiting related to viral gastroenteritis is the most common presentation to the Alberta Children's Hospital Pediatric Emergency Department. Recently, a clinical pathway was implemented to improve the care and flow of patients with vomiting and/or diarrhea through the department. Administration of an antiemetic, Ondansetron, is an integral part of improving the hydration status of children managed by the pathway. However it is not know whether Oral Solution or Oral Disintegrating Tablets are better tolerated in children who have active vomiting. The investigators aim to show that children receiving Oral Disintegrating Tablets have less vomiting immediately after medication administration than children receiving Oral Solution. By demonstrating this improved tolerability the investigators will provide health care providers the stimulus for implementing Ondansetron Oral Disintegrating Tablets into their practice for children with active vomiting. ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02174874
Study type Observational
Source Alberta Children's Hospital
Contact
Status Completed
Phase N/A
Start date June 2011
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT04682860 - Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide Phase 4
Recruiting NCT03851835 - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Phase 3
Completed NCT01577043 - Efficacy of Racecadotril in Acute Watery Diarrhea in Children Phase 4
Completed NCT03234777 - Evaluating a Knowledge Translation Tool for Parents N/A
Not yet recruiting NCT02619201 - Antiemetic Efficacy of Ondansetron Versus Metoclopramide Phase 3
Completed NCT02280759 - Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children. Phase 1
Completed NCT06090708 - Yogurt Probiotic Bacteria on Relieving Young Children Acute Gastroenteritis N/A
Recruiting NCT05270291 - Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis
Completed NCT02025452 - Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis Phase 4
Not yet recruiting NCT06038305 - Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis
Completed NCT02803827 - Optimizing the Management of Acute Diarrhoeal Disease Phase 3
Completed NCT02644200 - Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis Phase 3
Completed NCT03539913 - Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in Children Phase 4
Recruiting NCT06137014 - Fortified Oral Rehydration Therapy for Pediatric Diarrhea Phase 1/Phase 2
Completed NCT04463355 - Video Discharge Instructions for Pediatric Gastroenteritis in an Emergency Department N/A
Completed NCT04555200 - Continuous Enteral Rehydration by Nasogastric Tube With ORS in Children With Acute Gastroenteritis
Unknown status NCT02177799 - Surveillance Study of Acute Gastroenteritis in Hospitalized Children in Rural Area in Lebanon N/A
Completed NCT02169817 - Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children Phase 4
Completed NCT01886755 - Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis N/A
Completed NCT01257672 - Symptomatic Treatment of Acute Gastroenteritis Phase 3